Mechanistically, GPR35 modulates intracellular calcium levels, promotes receptor internalization, and activates ERK1/2 in GC via Gα13 and Gi/o signaling, thereby enhancing GC cell migration, invasion, and remodeling of the tumor microenvironment (52). The gene discussed is GPR35; the disease is neoplasm.